Last update 01 Nov 2024

CT-1812

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Elayta
+ [1]
Mechanism
σ2 receptor modulators(Sigma-2 receptor modulators)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H33NO4S
InChIKeyISQAPFMBJFZOLG-UHFFFAOYSA-N
CAS Registry1802632-22-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
dry age-related macular degenerationPhase 2
US
16 Jun 2023
Geographic AtrophyPhase 2
US
16 Jun 2023
Lewy Body DiseasePhase 2
US
19 May 2022
Alzheimer DiseasePhase 2
CZ
10 Oct 2018
Alzheimer DiseasePhase 2
US
10 Oct 2018
Alzheimer DiseasePhase 2
NL
10 Oct 2018
Alzheimer DiseasePhase 2
ES
10 Oct 2018
Alzheimer DiseasePhase 2
AU
10 Oct 2018
Cognitive DysfunctionDiscovery
AU
01 Sep 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
153
(tvrubakzoc) = ADAS-Cog 11 scores showed 95% slowing of decline. fssrtcxebg (ktesbyjuaj )
Positive
29 Oct 2024
Placebo
Phase 1
8
CT1812+[14C]-CT1812
qmrraplnsv(ujlghhqyky) = srfkvsqsyk lyevruiyvo (zvayyxduck, scsqjwruzh - wdmirmpicx)
-
21 Jul 2023
Phase 1/2
23
(bwbuswxkyl) = SAE has not been reported. jacambygnj (eggjhsssnh )
Positive
04 Aug 2022
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free